Thursday, March 7, 2013
Immunovaccine Inc., of Halifax, Nova Scotia, closed the previously announced private placement of its securities, raising gross proceeds of about $1.6 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.